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The cyclin-dependent kinase inhibitor p21WAF1/Cip1 plays a central role in a spatial and temporal balance of epidermal keratinocyte
proliferation and growth arrest. However, what controls p21 expression in keratinocytes remains uncertain. Hypoxia-inducible factor 1α (HIF-1α)
does not only express a variety of genes essential for hypoxic adaptation, but also up-regulates p21 so as to slow down cell cycle under hypoxic
conditions. In the present study, we examined the role of HIF-1α in p21-mediated growth arrest of keratinocyte. Keratinocyte proliferation was
arrested in the G1 phase at a high cell density. p21 was also up-regulated in a cell density-dependent manner and was found to be highly expressed
in epidermal keratinocytes of normal human skins. In addition, in the same specimens and cells, we noted robust HIF-1α expression. HIF-1α
siRNAs inhibited p21 expression and released the G1 arrest. In vivo, moreover, the intradermal injection of HIF-1α siRNA attenuated p21
expression in rat epidermis and induced skin hyperplasia. Mechanistically, we propose that the production of mitochondrial reactive oxygen
species and the activation of the MEK/ERK pathway are involved in the HIF-1α stabilization in keratinocytes. These results imply that HIF-1α
functions as an up-stream player in the p21-mediated growth arrest of keratinocytes.
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doi:10.1016/j.bbamcr.2007.11.017are newly generated from stem cells in basal layers, and undergo
a sequential multi-step differentiation, i.e., growth arrest –
migration to suprabasal layers – apoptosis — and finally cor-
nification. Moreover, the rates of proliferation and growth arrest
are precisely balanced by desquamation of the cornified layer,
and this process maintains the epidermal thickness [1–3]. Thus,
an increase in proliferation or low growth arrest may cause
hyperproliferative skin disorders. Then which molecular enti-
ties are key players in epidermal homeostasis? The answer to this
question may provide a clue to the prevention and treat-
ment of hyperproliferative skin disorders. In this work, we focus
on the mechanism underlying the growth arrest of keratinocytes.
The cyclin-dependent kinase inhibitor p21WAF1/Cip1 has been
shown to play an important role in the control of keratino-
cyte growth and differentiation, as it does in many terminally
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of keratinocyte growth arrest and differentiation by Ca2+ [5,6],
TPA [6] or interferon-γ [7]. Although the p21-mediated cell
cycle arrest is well known in many cell types, the contribution
made by p21 to epidermal differentiation remains ambiguous. In
studies by Paramio et al. [8], p21 knock-out failed to affect
keratinocyte growth rates. In contrast, in different studies using
similar culture models, p21 knock-out showed significantly
increased proliferative potential of keratinocytes [9,10]. In
addition, it was also demonstrated that Ras-transformed, p21-
knocked-out keratinocytes exhibit highly aggressive tumori-
genic behavior in nude mice and that p21 knock-out mice are
more susceptible to carcinogen-induced tumorigenesis in theFig. 1. p21 expression and cell cycle arrest in human keratinocytes. A) Cell density-
cell densities, cell cycle was analyzed by propidium iodide staining and flow cytome
either the 20% or 40% confluence group. B) mRNA levels of cell cycle inhibitors. Tot
determined by semiquantitative RT-PCR. C) Cell density-dependent expression of p
protein levels were analyzed by immunoblotting. D) p21 expression in human epiderm
anti-p21 antiserum or preimmune rabbit serum (-antibody). p21 (arrow) was identified
in proliferating keratinocytes. Immunofluorescence staining for p21 (Alexa Fluor 488
blue staining (for labeling all nuclei). Keratinocytes expressing p21 (green) do not oskin. Therefore, p21 up-regulation in keratinocytes is believed
to contribute to growth arrest. However, the factors that control
p21 expression in keratinocytes have not been determined.
HIF-1α is an up-stream factor that induces p21 transcription.
Originally, HIF-1α was found to be a key transcription factor of
the hypoxic induction of erythropoietin. As 60 or more genes
that are essential for hypoxic adaptation are up-regulated
by HIF-1α, it is now viewed as a master protein that directs
angiogenesis and cell survival [11]. HIF-1α belongs to the
basic-helix–loop–helix Per-Arnt-Sim family, and is O2-depen-
dently regulated at the post-translational level [12]. Under
normoxic conditions, HIF-1α is hydroxylated by HIF-1-prolyl
hydroxylases, and then ubiquitinated and degraded by Vondependent G1 arrest. After HaCaT cells had been cultured to reach the indicated
try. Each bar represents the mean±SD of 9 separate experiments. ⁎: pb0.05 vs.
al RNAs were extracted and the mRNA levels of p21, p27, p53, and β-actin were
21 in keratinocytes. In HaCaT cells and primary keratinocytes, p21 and β-actin
al keratinocytes. Biopsy sections from human normal skin were incubated with
at a magnification of 100×. [E], epidermis; [D], dermis. E) p21 is not expressed
green) and Ki67 (Alexa Fluor 568 red) was performed in combination with DAPI
verlap with proliferating keratinocytes expressing Ki67 (red).
Fig. 1 (continued).
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limits this modification of HIF-1α, and thereby stabilizes HIF-
1α, which associates with ARNT and transactivates genes
[13,14]. In addition to this role, HIF-1α is known to induce p21
expression by inhibiting c-Myc, a repressor of the p21 gene.
HIF-1α down-regulates c-Myc by disorganizing β-catrenin/
Tcf4 transcription factor for c-Myc expression [15], and also
derepresses p21 by displacing c-Myc binding from p21 pro-
moter [16]. However, since all of these findings have
been reported only in cancer cells, it is uncertain whether
HIF-1α-dependent cell cycle arrest occurs in non-cancerous
cells. In the present study, we demonstrated that HIF-1α func-
tions as an up-stream player in the p21-mediated growth arrest
of keratinocytes.
2. Materials and methods
2.1. Reagents and antibodies
Desferrioxamine (DFO), cycloheximide (CHX), N-acetyl cysteine (NAC),
dithiothreitol (DTT), rotenone (ROT), 4, 4′-diisothiocyanatostilbene-2, 2′-
disulfonic acid (DIDS), 2′,7′-dichlorofluorescein diacetate (DCFDA), and other
chemicals were purchased from Sigma-Aldrich Corp (St. Louis, MO). Protein
kinase inhibitors PD98059, U0126, wortmannin, LY294002, SB202190,
calphostin C, and herbimycin A were purchased from Alexis Biochemicals
(Lausen, Switzerland). [α-32P]CTP (500 Ci/mmol) was from NEN Life Science
(Boston, MA), and serum-free keratinocyte media (KSFM) from Cambrex BioSci. (Walkersville, MD). Other culture media, Hanks' balanced salt solution, and
fetal calf serum were purchased from Invitrogen Corp. (Carlsbad, CA). For an
effective transfer of O2 and CO2 in some experiments, cells were cultured in gas-
permeable, Lumox™ culture dishes purchased from Greiner Bio-One (Frick-
enhausen, Germany). Anti-human HIF-1α and anti-rat HIF-1α antisera were
generated in rats or in mice against bacterially expressed fragments encom-
passing amino acids 418–698 of human HIF-1α or rat HIF-1α, as previously
described [17]. Antibodies against MEK-1, ERK, and their phosphorylated
forms were purchased from Cell Signaling Technology (Danvers, MA). Other
antibodies, rabbit anti-p21WAF1/Cip1, goat anti-ARNT, mouse anti-β-actin,
mouse anti-c-Myc, rabbit anti-Ki67, and HRP-conjugated secondary antibo-
dies were purchased from SantaCruz Biotechnology Inc. (Santa Cruz, CA).
Fluorescence probes (Alexa Fluor 488 green and Alexa Fluor 568 red) were
purchased from Invitrogen (Carlsbad, CA).
2.2. Cell culture
Primary human keratinocytes were cultured from human foreskin samples.
The skin specimens were incubated in Hanks' balanced salt solution containing
10 mg/ml dispase to separate the epidermis and dermis [18]. Sheets of epidermis
were dissociated using 0.25% trypsin and 1 mM EDTA, and isolated cells were
plated in KSFM at 1–3×106 cells per 100-mm dish. The cells were then grown
at 37 °C in a 5% CO2 atmosphere, split in a 1:4 ratio when 60% confluent, and
used for experiments at the third passage. HaCaT human keratinocytes, HEK293
human embryonal kidney, and Hep3B human hepatoma cell-lines were cultured
in RPMI-1640 medium, Dulbecco's modified Eagle's medium, or α-modified
Eagle's medium. All culture media were supplemented with 10% heat-
inactivated FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. All cells
were grown in a humidified 5% CO2 atmosphere at 37 °C in an incubator. When
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100% of confluence at harvest. After determining cell densities under an in-
verted microscope, cells were used for experiments.
2.3. Preparation of siRNAs and transfection
To knock-down HIF-1α, synthesized siRNA duplexes were obtained from
Invitrogen. The sequences targeting HIF-1α (GenBank number NM_001530)
corresponded to nucleotides 994–1018 (siRNA-I), 1204–1228 (siRNA-II), and
360–384 (siRNA-III) of the coding region. For transient transfection, about 40%
confluent cells in 60-mm cell culture dishes were transfected with 40 nM siRNA
using Lipofectamine (Invitrogen). Cells were allowed to stabilize for 48 h before
being used in experiments. To in vivo knock-downHIF-1α in rat skins, a rat HIF-
1α siRNAwas designed, based on nucleotides 370–387 of the coding region of
the rat HIF-1α gene (NM_024359). The HIF-1α siRNA solutions (80 nM) were
made in 50 μl of Lipofectamine and injected intradermally into sole skins of six
rats, and the control siRNA solutions were injected into the contra-lateral sole
skins. Six rats were treated with siRNAs 4 times (3 day intervals), and the sole
skins were removed at day 12 after injection started. All animal procedures were
performed according to the established procedures described in the Seoul
National University Laboratory Animal Maintenance Manual.
2.4. Immunoblotting
Total proteins were separated on 6.5% or 10% SDS/polyacrylamide gels, and
transferred to Immobilon-P membranes (Millipore, Bedford, MA), which were then
blocked with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween-20
(TTBS) at room temperature for 1 h, and incubated overnight at 4 °C with primary
antibodies diluted 1:1000 in 5% nonfat milk in TTBS. Membranes were then
incubated for 1 h with horseradish peroxidase-conjugated secondary antibodies
diluted 1:5000 in 5% nonfat milk in TTBS. Antigen–antibody complexes were
visualized using an Enhanced Chemiluminescence Plus kit (Amersham Biosciences,
Piscataway, NJ).
2.5. Semiquantitative RT-PCR
To quantify mRNA levels, we used a highly sensitive, semiquantitative RT-
PCR method, as previously described [17]. Total RNAs were isolated from
cultured cells using TRIZOL (Invitrogen) and reverse-transcribed at 48 °C for
30 min. cDNAs were amplified over 18 PCR cycles (94 °C for 30 s, 53 °C for
30 s, and 68 °C for 30 s) in a 20 μl of reaction mixture containing 5 μCi [α-32P]
dCTP and 250 nM of each primer. PCR products (5 μl) were electrophoresed on
4% polyacrylamide gels, and dried gels were autoradiographed. The nucleotide
sequences (5′ to 3′) of the primer pairs were; GATGGAACTTCGACTTTGTC
and GAAATCTGTCATGCTGGTCT for p21, CAGAATCACAAACCCC-
TAGA and CCGTCTGAAACATTTTCTTC for p27, and ATGGAGGAGCCG-
CAGTCAGATand TGGTAGGTTTTCTGGGAAG for p53. Primers for VEGF,
PGK 1, enolase 1, and β-actin were constructed as previously described [17].
2.6. Immunohistochemistry
HIF-1α and p21 were analyzed by immunohistochemistry staining in
formalin-fixed, paraffin-embedded biopsy sections of human or rat skin. Six-
micrometer serial sections were cut from each paraffin block, and immunostained
by deparaffinizing and rehydrating through a graded alcohol series. Antigens
were retrieved by heating the sections in a microwave for 5 min in 10mM sodium
citrate (pH 6.0). After blocking nonspecific sites, sections were incubat-
ed overnight at 4 °C with anti-p21 (1:100 dilution) or anti-HIF-1α (1:100)
antibodies. Control slides were not treated with primary antibodies. To visualize
HIF-1α, sections were stained using a standard method [19], avidin–biotin–
horseradish peroxidase complex was used to localize bound antibody, and
diaminobenzidine was used as the final chromogen. To visualize p21, sec-
tions were stained using the Tyramide Signal Amplification Biotin sys-
tem (PerkinElmer Life Sciences, Boston, MA) and diaminobenzidine. For
histological assessment, HIF-1α and p21 were identified at magnifications of
100×.2.7. Dual fluorescence staining for p21 and Ki67
Skin biopsy slides were deparaffinized, rehydrated, and heated in 10 mM
sodium citrate (pH 6.0). After blocking nonspecific sites, sections were co-
incubated overnight at 4 °C with rabbit anti-Ki67 and mouse anti-p21 antisera
(1:100). The slides were incubated for 1 h with Alexa Fluor 568 (red)-conjugated
goat anti-rabbit IgG (1:1000) for Ki67 staining. The slides were further incubated
with biotinylated goat anti-mouse IgG (1:1000) for 1 h, treatedwith streptavidin–
HRP (1:100) (Perkin Elmer, Torrance, CA) for 30 min, incubated with the
biotinylated tyramide amplification reagent (1:50) for 10 min, and finally reacted
with Alexa Fluor 488 (green)-conjugated streptavidin (1:1000) for 1 h. All nuclei
were counterstained with 0.1 μg/ml of DAPI (blue). Fluorescence images
were observed using an IX71 microscope (Olympus, Hamburg). Images were
captured using an UIS 2 Olympus camera running Image pro Plus 5.1 software
(Olympus).
2.8. Cell cycle analysis
HaCaT cells were cultured at densities of 20%, 40% or 80% of confluence,
harvested, and fixed in 75% ethanol for 30 min on ice. After washing with PBS,
cells were labeled with propidium iodide (0.05 mg/ml) in the presence of RNase
A (0.5 mg/ml), and incubated at room temperature in the dark for 30 min.
Propidium iodide incorporated into DNAwas excited at 488 nm and detected at
650 nm, using a FACStar flow cytometer (BD Biosciences).
2.9. ROS detection
HaCaT cells were cultured at densities of 40% or 80% of confluence. After
washing cells in pre-warmed PBS, culture media were replaced with a Hank's
Balanced Salt Solution that had been pre-incubated at 37 °C in a 5% CO2
atmosphere. Cells were then treated with 50 μMDCFDA for 30 min in the dark,
and detached with trypsin–EDTA solution. After a brief washing, the oxidized
form of DCFDA, fluorescent dichlorofluorescein was excited at 488 nm and
detected at 530 nm, using a FACStar flow cytometer.
2.10. Statistical analysis
All data were analyzed using Microsoft Excel 2002 software, and results are
expressed as means and standard deviations. The Mann–Whitney U test (SPSS
10.0 for Windows, Chicago, IL) was used to compare cell cycle phases, protein
levels, and reporter activities. Differences were considered statistically
significant at the pb0.05 level. All statistical tests were two-sided.
3. Results
3.1. Cell cycle arrest and p21 expression depend on
keratinocyte cell density
The transition from highly proliferative cell at low cell density
to stationary cell at high cell density is the earliest event in
the program of keratinocyte terminal differentiation [20].
As expected, at a cell density of 80%, the G1 population sig-
nificantly increased at the expense of the S and G2/M populations
in HaCaT cells (Fig. 1A). We next examined the mRNA levels of
the cyclin inhibitors p21, p27, and p53, and found that p21mRNA
was induced in a cell density-dependent manner (Fig. 1B). The
cell density-dependent expression of p21 protein was also
identified in both HaCaT cells and primary epidermal keratino-
cytes (Fig. 1C). However, p21 was barely detected in human
normal skins by conventional immunohistochemistry using
avidin–biotinylated enzyme complex (ABC). To increase the
sensitivity of immunohistochemistry, we stained p21 with the
Tyramide Signal Amplification (TSA) Biotin system, which was
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fold versus the conventional ABC system [21]. As a result, p21
was successfully detected in the nuclei of epidermal keratinocytes
in human normal skins (Fig. 1D), as previously reported [22]. To
examine the role of p21 in keratinocyte growth arrest, p21 and
Ki67 (amarker for proliferating cell) were co-stained in the human
skin tissues and visualized under fluorescent microscopy. Fig. 1E
shows that red Ki67 and green p21 were rarely merged in kera-
tinocytes, indicating that p21 was expressed only in non-
proliferating keratinocytes. This result further supports that p21
expression is associated with keratinocyte growth arrest.Fig. 2.HIF-1α expression in human keratinocytes. A) Cell density-dependent expression of
HaCaT cells were cultured to reach the indicated cell densities, or treated with 130 μM
immunoblotting. B) HIF-1α expression in other human cells. In HEK293 and Hep3B cells c
C) Oxygen tension in culture media. HaCaT cells were cultured to reach the indicated cell
Dissolved OxygenMeter with oxygen electrode provided fromWorld Precision Instruments
D)Cell density-dependent expressionsofHIF-1α andp21 ingas-permeable dishes.HaCaTce
and HIF-1α and p21 were analyzed by immunoblotting. E) Expression of hypoxia-induced
(Enol 1), phosphoglycerate kinase 1 (PGK 1), and β-actin were determined by semiquant
confluencewere incubatedunder normoxic (N) or hypoxic (H) conditions for 16h, and thenp3.2. HIF-1α is expressed in keratinocytes and mediates growth
arrest
As was observed for p21 expression, HIF-1α was induced in
a cell density-dependent manner in both primary epidermal
keratinocytes and HaCaT cells (Fig. 2A). Although non-
keratinocyte cell-lines HEK293 and Hep3B are capable of
expressing HIF-1α in response to desferrioxamine, they did not
express HIF-1α at high cell density (Fig. 2B). To rule out the
possibility that the 80% confluence makes the medium hypoxic
and consequently induces HIF-1α, oxygen dissolved in theHIF-1α in human keratinocytes. Keratinocytes isolated from human normal skin and
desferrioxamine (DFO) for 8 h. HIF-1α and β-actin expressions were analyzed by
ultured to reach the indicated cell densities, HIF-1αwas analyzed by immunoblotting.
densities, and partial pressure of oxygen dissolved in the media was measured using
(Sarasota, FL). The mean (% O2) and SD values were calculated from 3 experiments.
llswere cultured to reach the indicated cell densities inLumoxoxygenpermeable dishes,
genes. In HaCaT cells reaching the indicated cell densities, mRNA levels of enolase 1
itative RT-PCR. F) Hypoxic responses of HaCaT cells. HaCaT cells in 40% or 80%
roteins andmRNAswere analyzedbyWestern blotting (WB) andRT-PCR, respectively.
Fig. 3.HIF-1α-dependent p21 expression and cell cycle arrest.A) p21 and c-Myc expressions inHIF-1α knocked-down cells. HaCaTcells were transfectedwith 40 nMof
HIF-1α-silencing siRNAs I, II, III, or a scrambled RNA control (SC RNA). HIF-1α and p21 levels were analyzed by immunoblotting. B) Rescue of G1 arrest by HIF-1α
knock-down.HaCaTcells were transfected with siRNA-III, and cultured until 80% confluent. Cell cycleswere analyzed by propidium iodide staining and flow cytometry.
Each bar represents the mean±SD of 6 separate experiments. ⁎: pb0.05 vs. either theMock or SCRNA group. C) p21 and c-Myc expressions in HIF-1α expressing cells.
To induceHIF-1α, HaCaTcells were incubated with 130 μMdesferrioxamine (DFO), 100μMCoCl2 or 5 nMbafilomycin A1, or under hypoxic conditions for 16 h. HIF-
1α, p21, and c-Myc levels were analyzed by immunoblotting.D) c-Myc expression does not depend on cell density. After primary keratinocytes andHaCaTcells had been
cultured to reach the indicated cell densities, c-Myc levels were analyzed by immunoblotting.
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tended to decrease in cell density-dependent manner, but the
oxygen drop in 80% confluence was not significant (−1.4%,
p=0.25) compared to that in 40% confluence (Fig. 2C). To
prevent the oxygen drop during sub-confluent or confluent
culture, HaCaT cells were cultured in gas-permeable dishes, and
it was found that HIF-1α and p21 expressions were still induced
in a cell density-dependent manner (Fig. 2D). Compared to those
in 80% confluence, both expressions further increased in 100%
confluence. Moreover, mRNAs of hypoxia-induced genes, such
as enolase 1 and PGK 1, were not induced in 80% confluence
(Fig. 2E), whereas they were noticeably induced by hypoxia in
both 40% and 80% confluence (Fig. 2F). These results suggest
that the cell density-dependent HIF-1α expression is a unique
feature of epidermal keratinocyte, rather than a hypoxic event.
3.3. HIF-1α mediates keratinocyte growth arrest
To examine whether HIF-1α mediates p21 expression and
growth arrest, we knocked-down HIF-1α using 3 different
siRNAs (I, II and III). All HIF-1α siRNAs effectively redu-ced HIF-1α expression in keratinocytes. Concomitantly, these
siRNAs noticeably reduced p21 expression (Fig. 3A) and released
G1 arrest at a cell density of 80% (Fig. 3B). These results suggest
that HIF-1α plays an up-stream player in p21 expression and
growth arrest of keratinocytes. In terms of p21 induction by HIF-
1α, twomechanisms have been proposed; c-Myc downregulation
due to disruption of the β-catenin/TCF4 complex [15] and c-Myc
displacement from p21 promoter [16]. Since the latter event
induces p21 without any change in c-Myc expression, c-Myc
measurement can provide an indirect evidence in identifying
which event contributes to p21 induction in keratinocytes. In spite
of p21 suppression, c-Myc levels were not altered by HIF-1α
knock-down (Fig. 3A). When HIF-1α was induced under nor-
moxic or hypoxic conditions, p21 expression was all induced in
HaCaT cells. However, c-Myc expression was not repressed
by normoxic HIF-1α induced by chemical inducers, whereas it
was noticeably reduced by hypoxic HIF-1α (Fig. 3C). Moreover,
c-Myc expression was not affected by cell density under nor-
moxic conditions (Fig. 3D). Based on these results, the HIF-1α-
mediated p21 induction in normoxic keratinocytes may be
attributed to the c-Myc displacement from p21 promoter, rather
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HIF-1α regulates p21 expression in different ways under
normoxic and hypoxic conditions. The exact mechanism under-
lying the cell density- and HIF-1α-dependent induction of p21
in keratinocytes remains to be further investigated.
3.4. HIF-1α is expressed in the epidermis and associated with
epidermal homeostasis
In specimens of human normal skin, HIF-1α was found to be
robustly expressed in the nuclei of epidermal keratinocytesFig. 4.HIF-1α expression and its role in the epidermis.A)HIF-1α expression in human
antiserum or preimmune rabbit serum (-antibody). HIF-1α (arrow) was identified at a m
knocked-down skins. Six rats were treated with rat HIF-1α siRNA (siHIF), control RN
skins were immunostained with HIF-1α (blue arrow) and p21 (red arrow) antisera, a
thickening by knocking-down HIF-1α. The siRNA-treated plantar skins were stained
selected regions from each slide. Measurements were performed at a magnification
presented as the means±SD of samples from 6 rats.(Fig. 4A). To in vivo examine the role of HIF-1α in epidermal
homeostasis, we treated a rat HIF-1α siRNA into rat plantar
skins for 12 days, and confirmed that keratinocyte HIF-1α
expression was inhibited (Fig. 4B, left panel). As shown in
cultured keratinocytes, p21 expression in the epidermis of rat
plantar skins was also attenuated after HIF-1α siRNA treatment
(Fig. 4B, right panel). To examine whether HIF-1α controls
epidermal proliferation, the rat plantar skin slides were stained
with H&E dyes. The epidermal layers in HIF-1α siRNA-treated
soles became significantly thicker, compared to those in the
contra-lateral soles treated with the control RNA (Fig. 4C).skins. Biopsy sections fromhuman normal skinwere incubatedwith anti-HIF-1α
agnification of 100×. [E], epidermis; [D], dermis. B) p21 suppression in HIF-1α
A (SC), or Lipofectamine (Mock) solutions 4 times (3 day intervals). Rat plantar
nd examined at 100×. Results are representative of 6 experiments. C) Epidermal
with H&E dyes, and the thickness of the epidermis was analyzed in 12 randomly
of 40× with the investigator blinded as to the identity of the samples. Data are
Fig. 5.HIF-1α stabilization in keratinocytes. A) HIF-1αmRNA expression. After HaCaT cells had been cultured to reach the indicated cell densities, total RNAs were
extracted. The mRNA levels of HIF-1α and β-actin were determined by semiquantitative RT-PCR. B) HIF-1α protein synthesis. 40% or 80% confluent HaCaT cells
were treated with 60 μg/ml of cycloheximide for 30 min to remove remaining HIF-1α. To start HIF-1α synthesis, cells were washed with PBS and incubated in fresh
media containing 10 μMMG132 (used to prevent the degradation of newly synthesized HIF-1α), and HIF-1α levels were determined by immunoblotting. C) HIF-1α
protein stability. HaCaT cells were cultured until 40% or 80% confluent and then treated with 60 μg/ml of cycloheximide (CHX). After 2, 5, 10, and 20 min, HIF-1α
levels were analyzed by immunoblotting (left panel). Protein band intensities were quantified using ImageJ 1.36b and are plotted (right panel). Half-lives (t1/2) were
calculated from the slopes of first-order decay curves. Each point represents the mean value of 3 separate experiments.
Fig. 6. Signaling for HIF-1α stabilization. A) Involvement of the MEK-ERK
pathway in HIF-1α expression. 80% confluent HaCaT cells were treated with
various kinase inhibitors for 2 h, i.e., C, untreated control; CA, 1 μMcalphostin, a
PKC inhibitor; PD, 100 μM PD98059, a MEK-1 inhibitor; U, 10 μM U0126,
a MEK-1 inhibitor; W, 200 nM wortmannin, a PI3K inhibitor; LY, 20 μM
LY294002, a PI3K inhibitor; SB1, 5 μMSB202190, a p38MAPK inhibitor; HE,
1 μM Herbimycin A, a tyrosine kinase inhibitor. HIF-1α and p21 levels were
analyzed by immunoblotting. B) Cell density-dependent activation of MEK and
ERK. HaCaT cells were cultured until 20–80% confluent. MEK-1, ERK and
their active forms (phosphorylated forms) were analyzed by immunoblotting.
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epidermal homeostasis.
3.5. HIF-1α is stabilized density-dependently
How is HIF-1α regulated in keratinocytes? To answer this
question, we first measured the mRNA levels of HIF-1α, but
found that they did not increase (Fig. 5A). We also examined the
de novo synthesis of HIF-1α protein, but observed no
differences (Fig. 5B). We next compared the degradation rates
of HIF-1α protein, and found that HIF-1α degradation was
significantly delayed in 80% confluence vs. that in 40% con-
fluence (Fig. 5C, left panel). Based on protein band intensities,
protein half-lives (t1/2) were calculated from the slopes of first-
order decay curves (Fig. 5C, right panel). HIF-1α half-life was
prolonged to 8.47 min in 80% confluence (vs. 3.89 min in 40%
confluence). These results suggest that HIF-1α induction in
keratinocytes is attributable to stabilization at the protein level.
3.6. HIF-1α stabilization is mediated by mitochondrial ROS
and the MEK/ERK pathway
To identify the mechanism of HIF-1α stabilization, we exa-
mined the effects of various protein kinase inhibitors on HIF-1α
expression. Of these inhibitors, two MEK/ERK inhibitors abo-
lishedHIF-1α expression in 80% confluence (Fig. 6A), andMEKand ERK were activated in a cell density-dependent manner
(Fig. 6B), suggesting that the MEK/ERK pathway mediates HIF-
1α expression in keratinocytes. Thus, we addressed the up-stream
regulation of the MEK/ERK pathway. Reactive oxygen species
(ROS) are known to activate theMEK/ERKpathway, andAttene-
Fig. 7. HIF-1α stabilization by mitochondrial ROS. A) Cell density-dependent ROS production. HaCaT cells (cultured until 40% or 80% confluence) were stained for
intracellular ROS using DCFDA and the fluorescence was measured using a FACStar flow cytometer (left panel). To verify ROS-dependent fluorescence, cells were
pretreated with 2 mM DTT 30 min before DCFDA treatment. Fluorescence intensities are plotted (right panel). Each bar represents the mean±SD of 4 separate
experiments. B) MEK and ERK inhibition by antioxidants. 80% confluent HaCaT cells were treated with 2 mM DTT or 10 mM NAC for 2 h. MEK-1, ERK and their
phosphorylated formswere analyzed by immunoblotting. C) HIF-1α suppression by antioxidants. 80% confluent HaCaTcells were treatedwith DTT (1, 2 and 5mM) or
NAC (5, 10 and 20mM) for 2 h. D) HIF-1α suppression bymitochondrial inhibitors. 80% confluent HaCaTcells were treated with 1 μg/ml of ROTor 600 μMDIDS for
6 h. E) p21 suppression by antioxidants or mitochondrial inhibitors. 80% confluent HaCaTcells were treated with 5mMDTT, 20mMNAC, 1 μg/ml of ROT, or 600 μM
DIDS for 6 h. HIF-1α or p21 was analyzed as described in previous figures.
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grown intestinal epithelial cells [23]. Thus, we examined the
involvement of ROS in MEK/ERK activation and HIF-1α ex-
pression. Intracellular ROS levels were significantly higher in
80% confluence than those in 40% confluence (Fig. 7A). Here,
DTT was used to verify ROS-dependent fluorescence. Antiox-
idants DTT and NAC were found to block MEK/ERK activation
(Fig. 7B) andHIF-1α expression (Fig. 7C).We next examined the
possibility that mitochondria produce the ROS that underlie HIF-
1α expression. Accordingly, we used two inhibitors of mitochon-
drial ROS generation, rotenone and DIDS, which reduce ROS
production from mitochondria by inhibiting the respiratory chain
and by blocking the release of superoxide anions through mito-
chondrial anion channels, respectively. Both inhibitors werefound to reduce HIF-1α expression in 80% confluence (Fig. 7D).
Moreover, antioxidants and mitochondrial inhibitors all reduced
p21 expression in 80% confluence (Fig. 7E). Based on all results,
we propose a mechanism of growth arrest of keratinocytes, i.e.,
ROS generation by mitochondria –MEK/ERK activation –HIF-
1α stabilization – p21 induction, and finally cell cycle arrest.
4. Discussion
p21 is viewed as a prime contributor to the differentiation-
associated growth arrest, but little is known about the me-
chanism whereby p21 expression is regulated in keratinocytes.
In the present study, p21 was found to be expressed in human
skins and in cultured keratinocytes. Moreover, p21 expression
332 Y.-S. Cho et al. / Biochimica et Biophysica Acta 1783 (2008) 323–333and G1 arrest were found to be induced in a cell density-
dependent manner. Similarly, HIF-1α was also expressed in
human skins and induced in cultured keratinocytes density-
dependently. siRNA experiments revealed that HIF-1α deter-
mines p21 expression and keratinocyte growth arrest both in
vitro and in vivo. These findings imply that HIF-1α is involved
in epidermal homeostasis.
In terms of physiological roles, HIF-1α of keratinocyte is also
different from that of other cells. In spite of a noticeable
expression of HIF-1α, angiogenesis or glycolysis promoting
genes were not activated in keratinocytes, which suggests that
HIF-1α expressed at high cell density is not related to the
adaptation to hypoxia. Instead, keratinocyte HIF-1α functions as
the up-stream player in the p21-mediated growth arrest.
Previously, such a function of HIF-1α was described in cancer
cells cultured under hypoxic conditions [15,16], and this is
considered to underlie the tumor growth inhibition under hy-
poxic conditions. However, the HIF-1α-dependent growth arrest
has not been reported in normal tissues or cells. Our results
suggest that HIF-1α participates in the development of the
normal skin by controlling keratinocyte proliferation.
Since HIF-1α is degraded in a few minutes after de novo
synthesis, in most normal tissues HIF-1α is present at un-
detectable levels by immunoblotting [24,25]. Only when tissues
are subjected to ischemia or hypoxia, HIF-1α can be expressed at
detectible levels. Therefore, constitutive HIF-1α expression in
the normal human epidermis is a very interesting phenomenon.
What stimulates HIF-1α expression in the epidermis? Low
oxygen levels in the epidermis could be associated with HIF-1a
expression. Indeed, the oxygen status of skin remains con-
troversial despite many studies measuring oxygen partial
pressure in animal skins. However, a recent study using EF5
oxygen indicator demonstrated that the epidermis of human skin
is moderately hypoxic [26]. Then, the HIF-1α expression in
human or rat epidermis may be attributable to the physiologically
hypoxic environment in the epidermis. If this is the only reason
for HIF-1α expression, HIF-1α could not be expressed in
keratinocytes cultured in aerobic conditions. However, even after
being isolated from the epidermis, keratinocytes retain the ability
to constitutively express HIF-1α. Therefore, keratinocytes seem
to have a unique system to regulate HIF-1α.We here propose that
in addition to hypoxia, the ROS-MEK/ERK pathway signals the
constitutive expression of HIF-1α in the epidermis.
Despite substantial accumulation of HIF-1α in 80% con-
fluence, the transcriptions of genes directly govern by HIF-1
were not induced, which suggests that keratinocyte HIF-1α
expressed in normoxia has little transcription activity. In the
absence of a hypoxic signal, the transcriptional activity of HIF-
1α is known to be repressed by factor-inhibiting HIF (FIH). FIH
is an oxygen-dependent enzyme that hydroxylates an asparagine
residue (803) within the C-terminal transactivation domain of
HIF-1α and in turn blocks the recruitment of p300 co-activator
[27]. In hypoxia, FIH is inactivated due to limited oxygen, and
the unmodified HIF-1α can recruit p300 and actively express its
target genes. According to this regulation, keratinocyte HIF-1α
induced under normoxic conditions could be inactive in gene
transcription. In contrast, the p21 induction by HIF-1α does notrequire the activity of the transactivation domain of HIF-1α, or
rather it is achieved by its interaction with other proteins such as
c-Myc andβ-catrenin [15,16]. Since the N-terminal of HIF-1α is
necessary and sufficient for the protein interaction and p21
induction, keratinocyte HIF-1α having the interacting domain
can associate with these proteins and induce p21 expression,
despite a low transcriptional activity.
HIF-1α was stabilized in keratinocytes at high cell densities.
As cell density increases, the microenvironmental oxygen
tension around cells would be expected to fall, which may
stabilize HIF-1α. However, other types of cells did not express
HIF-1α even in sub-confluent cultures. Therefore, the oxygen
tension at a cell density of 80% might not drop to the critical
level required for HIF-1α stabilization, which was also
confirmed be measuring dissolved oxygen tension. Instead, we
found that intracellular ROS production significantly increased
in 80% confluent keratinocytes, and that antioxidants and
mitochondrial inhibitors prevented the HIF-1α expression.
These results suggest that mitochondrial ROS participate in
cell density-dependent HIF-1α expression in keratinocytes.
Similarly, ROS-dependent HIF-1α expression has also been
reported in other types of cells. Indeed, antioxidants including
ascorbate, vitamin E, pyrrolidinedithiocarbamate, and NAC
block the non-hypoxic induction of HIF-1α by thrombin, PDGF,
TGF-β, IGF-1, arsenite, or CoCl2 [28–30]. Although sources of
ROS generation and their specific relevance to HIF-1α
expression have not been fully resolved, mitochondria have
long been implicated in HIF-1α regulation. HIF-1α is
destabilized in mitochondria-deficient ρ0 [31] or complex III-
deficient cells [32,33], and the mitochondrion-targeting anti-
oxidant MitoQ prevents HIF-1α stabilization [34]. In terms of
signal transduction, three pathways have been suggested to be
responsible for non-hypoxic HIF-1α expression; phosphatidy-
linositol 3-kinase (PI3K), p38MAPK and p44/42MAPK (ERK)
[35]. Of these, ERK is more likely to mediate the cell density-
and ROS-dependent stabilization of HIF-1α in keratinocytes,
since MEK and ERK are both activated in a cell density-
dependent manner and inactivated by antioxidants. Moreover,
MEK/ERK inhibitors prevented HIF-1α expression, but PI3K
and p38 MAPK inhibitors did not. However, little is known
about the mechanism whereby ERK stabilizes HIF-1α.
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